Programpunkter

Poster session 1 (see also poster walks: 5 May 2026); Authors: Jennifer Goldschmidt, Darlaine Jantzen, Angela Wolff

Poster session 1 (see also poster walks: 5 May 2026); Authors: Bahale Mehale, Juan Bornman, Gouwa Dawood

Poster session 1 (see also poster walks: 5 May 2026); Authors: Corinne Auer, Erna Haraldsdottir, Karen Rennie, Irena Anna Frei

Poster session 1 (see also poster walks: 5 May 2026); Authors: Linda Haakseth, Caisa Öster, Kevin Mani, Anders Wanhainen, Eva Jangland

Poster session 1 (see also poster walks: 5 May 2026); Authors: Ben Sander

Healthcare’s growing reliance on AI, analytics, and cross-institution collaboration is constrained by fragmented data, strict regulation, and the lack of secure ways to use sensitive health data without losing control or trust. By separating data from systems and providing a secure execution layer that fits existing IT, healthcare organizations can generate reproducible evidence, enable secure collaboration, and accelerate innovation while retaining full control. This session presents a zero-trust, sovereignty-first approach where data stays inside the hospital or government’s own environment (on-prem or sovereign infrastructure) while analysis is executed locally and only non-identifiable results can be shared. 

The Nordics are at the forefront of digital health innovation. With some of the world’s most advanced healthcare systems, robust digital infrastructure, and a deeply rooted culture of collaboration and innovation, the region offers a uniquely dynamic environment for health tech and life science companies alike.Driven by a strong focus on prevention, precision medicine, and research excellence, the Nordic countries are actively shaping the future of healthcare, supported by strong public-private collaboration, world-class research institutions, and vibrant life science ecosystems spanning startups, academia, industry, and healthcare providers.This session offers a comprehensive introduction to both the Nordic healthcare systems and the broader life science ecosystems in each country. You will gain insights into how the systems are structured, where the real opportunities lie, what challenges to be aware of, and why the Nordics could be your ideal next market.

Presentation reviewing the importance of trustworthy AI in healthcare. Mechanisms for trust and improved compliance in delivering care.What is needed, why, and how to implement safely.

Building on last year’s introduction of Luxembourg - Japan initiative Data Spaces for Health, this session explores how trusted data sharing can evolve into clinically meaningful AI. Using Luxembourg-led initiative as a focal point, the talk focuses on the challenges health systems face when moving from shared data to trustworthy insights in dementia care and the problems that new collaborations such as AID-CARE are now beginning to address.

See separate program and registration online: gcpcc.org

Developing effective digital therapeutic tools requires more than technology - it demands deep collaboration with end-users. This presentation shares a methodological framework for co-creating VR therapy applications with therapists, psychologists, and educators. Drawing from our experience training 400+ professionals, conducting academically validated research with 100 children, and transitioning from educational to clinical applications, we offer practical insights for anyone developing digital health solutions through community-driven innovation.

Authors: Laura Frissen, Bram de Boer, Sil Aarts, Hilde Verbeek

Obesity affects more than 1 billion people globally and is projected to impact over 1.5 billion by 2035, creating one of the largest and fastest growing challenges for healthcare systems worldwide.
Source: World Health Organization Global Obesity Report.Barimetriq is an AI-powered platform designed to support long-term metabolic health across GLP-1 therapy, bariatric surgery and lifestyle pathways. The system combines predictive analytics, personalized AI coaching and continuous health data to help patients and clinicians detect early risk signals such as treatment plateau, metabolic decline or adherence challenges.By shifting obesity care from reactive treatment to continuous metabolic management, Barimetriq aims to improve patient outcomes while helping health systems manage the growing burden of obesity-related disease.